The Ackman-backed round funds a surface array that reads brain signals without pushing electrodes into tissue.
Elucid closes a $55M oversubscribed Series D to fund its FFR-CT launch and expand cleared AI plaque analysis.
AI revenue cycle startup Candid Health triples valuation with $120M Series D round as healthcare providers double down on automation.
The Series D funds targeted alpha therapy for solid tumors using AI-powered isotope targeting.